Rafael Holdings, Inc. (RFL)
NYSE: RFL · Real-Time Price · USD
1.750
+0.060 (3.55%)
Aug 1, 2025, 4:00 PM - Market closed
Splunk Employees
As of July 31, 2024, Rafael Holdings had 31 total employees, including 28 full-time and 3 part-time employees. The number of employees increased by 18 or 138.46% compared to the previous year.
Employees
31
Change (1Y)
18
Growth (1Y)
138.46%
Revenue / Employee
$23,613
Profits / Employee
-$738,516
Market Cap
61.41M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 31 | 18 | 138.46% |
Jul 31, 2023 | 13 | -10 | -43.48% |
Jul 31, 2022 | 23 | -39 | -62.90% |
Jul 31, 2021 | 62 | 2 | 3.33% |
Jul 31, 2020 | 60 | 9 | 17.65% |
Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
CBRE Group | 140,000 |
Equinix | 13,606 |
CoStar Group | 6,593 |
Public Storage | 5,900 |
American Tower | 4,691 |
Digital Realty Trust | 3,936 |
Crown Castle | 3,900 |
Simon Property Group | 3,000 |
RFL News
- 7 weeks ago - Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 2 months ago - Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering - GlobeNewsWire
- 2 months ago - Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - GlobeNewsWire
- 3 months ago - Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - GlobeNewsWire
- 3 months ago - Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - GlobeNewsWire
- 3 months ago - Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - GlobeNewsWire
- 4 months ago - Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals - GlobeNewsWire
- 5 months ago - Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewsWire